A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Paclitaxel/Carboplatin as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT00042302 · TERMINATED

Trial details

NCT number: NCT00042302
Sponsor: QLT Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Stage IIIb Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer

Start date: 2002-06-01
Primary completion: 2003-07-01
Enrollment: 540

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.